D9E-88944-80957
4 vaccinations
5 coded responses
33 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 1 — Pfizer-BioNTech
-
2021-02-12
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
-
2021-03-05
Dose 2 — Pfizer-BioNTech
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint pains, DiarrheaAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Fatigue or tirednessAdult check-in
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-04
- 2021-04-16
-
2021-06-04
Survey response — 3 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Delivered a babyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-04
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-09
-
2021-09-05
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid +MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-15
Dose 3 — Pfizer-BioNTech
-
2022-03-05
Survey response — 12 months, dose 2MedDRA: Arrhythmia, Arthralgia, Chest pain, Dizziness, Fatigue, Pain in extremity, Tachycardia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Post booster shot symptoms- tachycardia, arrhythmia, dizziness, extreme fatigue, arm/chest/shoulder sorenessMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Dose 4 — Pfizer-BioNTech
- 2022-10-07
-
2022-10-09
Health check-in — day 7, dose 4Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2022-10-16
Survey response — day 14, dose 4MedDRA: Injection site reaction — Feeling: GoodFree text: Injection site reaction after flu shot in same arm as Covid booster 1.5 weeks prior.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-25
-
2022-10-30
Survey response — day 28, dose 4MedDRA: Diarrhoea — Feeling: GoodFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-11-06
- 2022-11-13
- 2023-01-01
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-10-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — 3 months, dose 2
Symptoms: Delivered a baby
Release 9 — 6 months, dose 2
Symptoms: Covid +
Release 11 — 12 months, dose 2
Symptoms: Post booster shot symptoms- tachycardia, arrhythmia, dizziness, extreme fatigue, arm/chest/shoulder soreness
Release 12 — day 14, dose 4
Symptoms: Injection site reaction after flu shot in same arm as Covid booster 1.5 weeks prior.
Release 12 — day 28, dose 4
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arrhythmia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | COVID-19 | ✓ | · | ✓ |
| SD | Delivery | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site reaction | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release